Astec Lifesciences (NSE:ASTEC) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
75 GF Score
Price ₹725.45
GF Value ₹976.08
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Astec Lifesciences's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

NSE:ASTEC vs CTVA, CF: Margin of Safety % (DCF Earnings Based) Comparison

For the Agricultural Inputs subindustry, Astec Lifesciences's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astec Lifesciences Margin of Safety % (DCF Earnings Based) vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's Margin of Safety % (DCF Earnings Based) falls into.


NSE:ASTEC
75GF Score
Astec Lifesciences Ltd NSE:ASTEC
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹725.45 is trading 25.7% below its estimated GF Value™ of ₹976.08. GuruFocus considers Astec Lifesciences to be Modestly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹976.08 vs. price of ₹725.45 (25.7% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score

Get the complete analysis for NSE:ASTEC

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹725.45
Price
₹976.08
GF Value